BioCentury
ARTICLE | Clinical News

Gamunex immune globulin intravenous regulatory update

September 1, 2003 7:00 AM UTC

The FDA approved for marketing BAYG's Gamunex for patients with compromised immune systems. Gamunex, which was approved in Canada in August, will be available in Canada early next year and in the U.S....